My Cart [ 0 ]
New Products
New Services
News
Promotions
Home > Search Results
    32 products and services containing "tp53"
    Please click tp53 to try advanced search.
  • PA007513.m2a: In Vivo Grade Recombinant Anti-mouse VEGF Monoclonal Antibody (Clone: B20-4.1.1.1), Mouse IgG2a Kappa

    The in vivo grade recombinant anti-mouse VEGF mouse IgG2a kappa monoclonal antibody was produced in mammalian cells. 
    Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: B20-4.1.1.1) specifically binds to mouse VEGF.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse VEGF protein.

     

  • BP005457: Biotinylated Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Monomer Protein with the C-His-Avi Tag

    Source: The recombinant Biotinylated Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and HMTEVVRHC peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Anti-HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Antibody protein with the C-His-Avi tag at 5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Biotinylated Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Monomer protein with the C-His tag with the EC50 of 0.25 ug/ml determined by ELISA.
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP004740: Biotinylated Human HLA-A*02:01&B2M&P53 WT (HMTEVVRRC) Monomer Protein with the C-His-Avi Tag

    Source: The recombinant Biotinylated Human HLA-A*02:01&B2M&P53 WT (HMTEVVRRC) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and HMTEVVRRC peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity:
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP001892-PRO-051: Recombinant Human Chromosome 12 Open Reading Frame 5 (C12ORF5) Protein

    Source: E. coli-derived.
    Purity: > 90.0% as determined by SDS-PAGE.

  • BP001694-CE72: Recombinant Human Cyclin-Dependent Kinase Inhibitor 1 (CDKN1A) Protein

    Source: E. coli-derived.
    Purity: >95% by reducing SDS-PAGE.
    Endotoxin: < 0.1 ng/ug (1 IEU/ug).

  • BP000929-ENZ-460: Recombinant Human Guanidinoacetate N-Methyltransferase

    Source: E. coli-derived.
    Purity > 95%, by SDS-PAGE.

  • BP004505: Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Monomer Protein with the C-His-Avi Tag

    Source: The recombinant Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and HMTEVVRHC peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Anti-HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Antibody protein with the C-His-Avi tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Monomer protein with the C-His tag with the EC50 of 44.7 ng/ml determined by ELISA.
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP004504: Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Tetramer Protein with the C-His-Avi Tag

    Source: The recombinant Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Tetramer Protein, (amino acids Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and HMTEVVRHC peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Tetramer protein with the C-His-Avi tag at 5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Antibody protein with the C-hFc tag with the EC50 of 4.5 ng/ml determined by ELISA.
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP004216: Human HLA-A*02:01&B2M&P53 WT (HMTEVVRRC) Monomer Protein with the C-His-Avi Tag

    Source: The recombinant Human HLA-A*02:01&B2M&P53 WT (HMTEVVRRC) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and HMTEVVRRC peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity:
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP004215: Human HLA-A*02:01&B2M&P53 WT (HMTEVVRRC) Tetramer Protein with the C-His-Avi Tag

    Source: The recombinant Human HLA-A*02:01&B2M&P53 WT (HMTEVVRRC) Tetramer Protein, (amino acids Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and HMTEVVRRC peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity:
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

See our Privacy Policy